Table 6.
Selectivity
Matrix | Anticoagulant | ELX | ELX-IS | TEZ | TEZ-IS | IVA | IVA_IS |
---|---|---|---|---|---|---|---|
Plasma | K3EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 1.9 | 0.0 |
Plasma | K3EDTA | 0.0 | 0.2 | 0.0 | 0.0 | 1.2 | 0.0 |
Plasma | K3EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 1.5 | 0.0 |
Plasma | K3EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | 0.0 |
Plasma | K3EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 |
Plasma | K3EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 1.3 | 0.0 |
Plasma* | K2EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 2.3 | 0.0 |
Plasma* | K2EDTA | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Plasma* | K2EDTA | 0.0 | 0.0 | 0.0 | 0.0 | 2.6 | 0.0 |
Plasma** | K2EDTA | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 |
Plasma** | K2EDTA | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 |
Plasma** | K2EDTA | 0.0 | 0.1 | 0.0 | 0.0 | 1.5 | 0.0 |
Serum | - | 0.0 | 0.0 | 0.0 | 0.0 | 2.1 | 0.0 |
Serum | - | 0.0 | 0.0 | 0.0 | 0.0 | 2.5 | 0.0 |
Serum | - | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 |
| |||||||
mean response (% LLOQ) | 0.0 | 0.1 | 0.0 | 0.0 | 1.4 | 0.0 |
indicates hemolyzed (~550mg/dL)
indicates visual lipemia